Table 2. Ongoing international clinical trials of programmed cell death protein 1 and PD‐L1 inhibitors on lung cancer with participating Chinese centers (until April 25, 2018).
a
The registration numbers are from the China Food and Drug Administration database (www.chinadrugtrials.org.cn).
Abbreviations: EGFR, epidermal growth factor receptor; NSCLC, non‐small cell lung cancer; PD, pharmacodynamics; PD‐L1, programmed death‐ligand 1; SCLC, squamous cell lung cancer; TKI, tyrosine kinase inhibitor.